Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piergiorgio Modena

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Neuro-Oncology|March 14, 2023
Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA studyRebecca J Chapman, David R Ghasemi, Felipe Andreiuolo, et al.
Journal of Neuro-Oncology|July 9, 2022
How ten-years of reirradiation for paediatric high-grade glioma may shed light on first line treatmentMaura Massimino, Sabina Vennarini, Francesco Barretta, et al.
Neuro-Oncology|October 4, 2021
Treatment and outcome of intracranial ependymoma after first relapse in the 2nd AIEOP protocolMaura Massimino, Francesco Barretta, Piergiorgio Modena, et al.
Neuro-Oncology|November 2, 2020
Second series by the Italian Association of Pediatric Hematology and Oncology of children and adolescents with intracranial ependymoma: an integrated molecular and clinical characterization with a long-term follow-upMaura Massimino, Francesco Barretta, Piergiorgio Modena, et al.
Neuro-Oncology|September 27, 2024
Long-term outcome of the Milano-hyperfractionated accelerated radiotherapy strategy for high-risk medulloblastoma, including the impact of molecular subtypeMaura Massimino, Francesco Barretta, Chiara Dossena, et al.
Journal of Neuro-Oncology|August 16, 2018
Pediatric intracranial ependymoma: correlating signs and symptoms at recurrence with outcome in the second prospective AIEOP protocol follow-upMaura Massimino, Francesco Barretta, Piergiorgio Modena, et al.
Neuro-Oncology|May 20, 2016
Final results of the second prospective AIEOP protocol for pediatric intracranial ependymomaMaura Massimino, Rosalba Miceli, Felice Giangaspero, et al.
The Lancet. Oncology|August 14, 2018
Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour GroupStefan Rutkowski, Piergiorgio Modena, Daniel Williamson, et al.
Acta Neuropathologica|November 19, 2016
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variantsKristian W Pajtler, Stephen C Mack, Vijay Ramaswamy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2018
Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG RegistriesLindsey M Hoffman, Sophie E M Veldhuijzen van Zanten, Niclas Colditz, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Neuro-Oncology|March 14, 2023
Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA studyRebecca J Chapman, David R Ghasemi, Felipe Andreiuolo, et al.
Journal of Neuro-Oncology|July 9, 2022
How ten-years of reirradiation for paediatric high-grade glioma may shed light on first line treatmentMaura Massimino, Sabina Vennarini, Francesco Barretta, et al.
Neuro-Oncology|October 4, 2021
Treatment and outcome of intracranial ependymoma after first relapse in the 2nd AIEOP protocolMaura Massimino, Francesco Barretta, Piergiorgio Modena, et al.
Neuro-Oncology|November 2, 2020
Second series by the Italian Association of Pediatric Hematology and Oncology of children and adolescents with intracranial ependymoma: an integrated molecular and clinical characterization with a long-term follow-upMaura Massimino, Francesco Barretta, Piergiorgio Modena, et al.
Neuro-Oncology|September 27, 2024
Long-term outcome of the Milano-hyperfractionated accelerated radiotherapy strategy for high-risk medulloblastoma, including the impact of molecular subtypeMaura Massimino, Francesco Barretta, Chiara Dossena, et al.
Journal of Neuro-Oncology|August 16, 2018
Pediatric intracranial ependymoma: correlating signs and symptoms at recurrence with outcome in the second prospective AIEOP protocol follow-upMaura Massimino, Francesco Barretta, Piergiorgio Modena, et al.
Neuro-Oncology|May 20, 2016
Final results of the second prospective AIEOP protocol for pediatric intracranial ependymomaMaura Massimino, Rosalba Miceli, Felice Giangaspero, et al.
The Lancet. Oncology|August 14, 2018
Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour GroupStefan Rutkowski, Piergiorgio Modena, Daniel Williamson, et al.
Acta Neuropathologica|November 19, 2016
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variantsKristian W Pajtler, Stephen C Mack, Vijay Ramaswamy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2018
Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG RegistriesLindsey M Hoffman, Sophie E M Veldhuijzen van Zanten, Niclas Colditz, et al.
Pageof 6